Hemogenyx Pharmaceuticals PLC Strategic Asset Allocation Index

Latest as of June 2023: 95.8%

Hemogenyx Pharmaceuticals PLC strategic asset allocation index. Hemogenyx Pharmaceuticals PLC (HEMO) has a Strategic Asset Allocation Index of 95.8% as of June 2023. Strategic assets (PP&E of GBX3.48 Million plus long-term investments of GBX-) total GBX3.48 Million, measured against net assets of GBX3.63 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Hemogenyx Pharmaceuticals PLC balance sheet independence to measure how much of total assets are equity-financed.

SAAI

95.8%
Strategic Assets / Net Assets

Strategic Assets

GBX3.48 Million
PP&E + LT Investments

PP&E

GBX3.48 Million
GBX

Net Assets

GBX3.63 Million
GBX

Strategic Asset Allocation Index of Hemogenyx Pharmaceuticals PLC (2016–2021)

Strategic asset allocation index of Hemogenyx Pharmaceuticals PLC from 2016 to 2021. This chart shows how Hemogenyx Pharmaceuticals PLC's Strategic Asset Allocation Index has evolved across 5 annual periods from 2016 to 2021. As of June 2023, the index stands at 95.8%, representing strategic assets of GBX3.48 Million against net assets of GBX3.63 Million GBX. Check how tangible is Hemogenyx Pharmaceuticals PLC's equity to evaluate the tangible quality of the company's equity base.

Hemogenyx Pharmaceuticals PLC Strategic Asset Allocation Index by Year (2016–2021)

Hemogenyx Pharmaceuticals PLC strategic asset allocation index by year from 2016 to 2021. The table below presents the year-by-year Strategic Asset Allocation Index for Hemogenyx Pharmaceuticals PLC from 2016 to 2021, covering 5 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Hemogenyx Pharmaceuticals PLC market capitalisation.

Year SAAI Strategic Assets (GBX) PP&E LT Investments Net Assets Change (pp)
2021 9.8% GBX797.13K GBX797.13K GBX- GBX8.17 Million ▼ -20.9 pp
2020 30.7% GBX268.74K GBX268.74K GBX- GBX875.68K ▲ +12.6 pp
2018 18.1% GBX173.94K GBX173.94K GBX- GBX959.17K ▲ +9.1 pp
2017 9.0% GBX191.58K GBX191.58K GBX- GBX2.13 Million ▼ -10.5 pp
2016 19.5% GBX175.80K GBX175.80K GBX- GBX903.71K —
pp = percentage points